In melanoma, we now have identified sex‐related differences in the glycolytic signature, showing a significant increase in LDH‐A, HKII, and MCT4 levels in male melanoma, further supported by higher serum LDH levels in male patients. Here, SLC16A3 is linked to melanoma.